The role of community pharmacists in the identification and ongoing management of women at risk for perinatal depression: A qualitative study

Elkhodr, Sabrine; Saba, Maya; O’Reilly, Claire; Saini, Bandana

doi:10.1177/0020764017746198

Cited by 24 publications

(33 citation statements)

References 69 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…40 Different studies confirmed the capability of the pharmacist to be involved in screening programs and risk assessment services for depression. 41,42 Kondova et al 43 identified that 70% of all patients screened in a community…”

Section: Education Of the Patient And His/her Relatives/ Caregivers Gmentioning

confidence: 99%

<p>The Potential Role of the Pharmacist in Supporting Patients with Depression – A Literature-Based Point of View</p>

Kamusheva¹,

Ignatova²,

Gołda³

et al. 2020

IPRP

View full text Add to dashboard Cite

Objective: The current article is aimed at identifying the best practice for counseling around depression in community and outpatient pharmacies, resulting in a draft guideline, proposing key steps and an algorithm for integration of community pharmacists into care for patients with depression. Methods: A literature review was performed followed by a detailed analysis, for the purpose of creation a short draft document used as a basis for creation of a guideline for pharmaceutical care for patients with depression. The technological scheme PRISMA flow diagram was applied. The paper is based on current knowledge, taking into consideration already published articles, guidelines, and recommendations about pharmaceutical care for patients with depression, giving a basis for further studies. Results: This paper includes two main sections: 1) depressiona short description of the main symptoms, risk factors and pharmacotherapy guidelines available in Bulgaria important for the purposes of ensuring qualitative community-based pharmaceutical care; and 2) the pharmacists' role in providing high-quality carethe main aspects of pharmaceutical care for patients with depression with specific examples. Conclusion: The involvement of pharmacists in supporting depressive patients is crucial taking into account the specific characteristics of the pharmacological treatment: delayed onset of clinical results, risks in case of sudden pharmacotherapy abruption without physician consultation, multiple adverse drug reactions and drug-drug, drug-food and drugalcohol interactions, etc. The current article could also be used as an initial document for creating a methodological guideline for providing pharmaceutical care services for patients with depression.

show abstract

Section: Education Of the Patient And His/her Relatives/ Caregivers Gmentioning

confidence: 99%

<p>The Potential Role of the Pharmacist in Supporting Patients with Depression – A Literature-Based Point of View</p>

Kamusheva¹,

Ignatova²,

Gołda³

et al. 2020

IPRP

View full text Add to dashboard Cite

show abstract

“…While the role of some specific healthcare professionals, such as pharmacists, was not specifically mentioned in regard to screening, with terminology alluding to “all” and “primary” healthcare professionals within included publications, perhaps their role in screening is implied in some recommendations. However, healthcare professionals frequently report that formal perinatal mental health education is insufficient in curricula (Elkhodr et al 2018 ; Legere et al 2017 ; Sambrook Smith et al 2019 ). Hence, there is a need to develop, evaluate and integrate purpose-designed education with input from mental health professionals and consumers.…”

Section: Discussionmentioning

confidence: 99%

“…Concerns surrounding screening also often include debate as to whether routine screening is acceptable (AE Buist et al 2002 ); however, a systematic review exploring acceptability among key stakeholders, demonstrated that screening is generally acceptable to perinatal women and health professionals (El-Den et al 2015 ). There is a growing body of evidence relating to PND screening by a range of health care professionals, such as physicians (Ford et al 2017 ), nurses (Segre et al 2010 ), midwives (Martin et al 2020 ), paediatricians (Byatt et al 2013 ; Chambers et al 2019 ; Currie & Rademacher 2004 ) and pharmacists (El-Den et al 2019 ; Sarira El-Den et al 2018a , b , c ; Elkhodr et al 2018 ); hence, it is often unclear which provider is responsible for screening and there is growing support for integrating early detection in all “medical settings that encounter perinatal women” (Flynn et al 2006 ). If screening is to be delivered in a variety of medical settings, then in addition to ensuring healthcare professionals working in those settings are trained, there is a need to also ensure that appropriate, site-specific follow-up and referral pathways for diagnostic assessment and treatment are also established.…”

Section: Introductionmentioning

confidence: 99%

Perinatal depression screening: a systematic review of recommendations from member countries of the Organisation for Economic Co-operation and Development (OECD)

El-Den

Pham

Yang

et al. 2022

Arch Womens Ment Health

View full text Add to dashboard Cite

Perinatal depression (PND) screening recommendations are made by national, state-based and professional organisations; however, there is disagreement regarding screening timing, provider responsible, screening setting, screening tool as well as the follow-up and referral pathways required post-screening. This systematic review aimed to identify, describe and compare PND screening recommendations from member countries of the Organisation for Economic Co-operation and Development (OECD). Publications were identified through systematically searching PubMed, Google and the Guidelines International Network (GIN). Recommendations regarding PND screening endorsement, timing, frequency, responsible provider, tools/assessments and follow-up and referral were extracted. Twenty-one publications, including guidelines, from five countries were included. Most made recommendations in support of PND screening using the Edinburgh Postnatal Depression Scale. Details differed regarding terminology used, as well as frequency of screening, follow-up mechanisms and referral pathways. A broad range of health providers were considered to be responsible for screening. This is the first review to identify and compare PND screening recommendations from OECD member countries; however, only online publications published in English, from five countries were included. Heterogeneity of publication types and inconsistency in definitions rendered quality assessment inappropriate. While most publications generally endorsed PND screening, there are exceptions and the associated details pertaining to the actual conduct of screening vary between and within countries. Developing clear, standardised recommendations based on current evidence is necessary to ensure clarity amongst healthcare providers and a comprehensive approach for the early detection of PND.

show abstract

“…19,20 Furthermore, research exploring pharmacist-led screening for mental illnesses is also emerging, with exploratory research being conducted in the areas of perinatal depression screening as well as pilot studies demonstrating the feasibility of depression screening within community pharmacy. [21][22][23][24] A recent systematic review of community pharmacist-led depression screening for adults found that while pharmacists could use screening tools to identify people living with undiagnosed depression, there was a need for more robust, high-quality research in this area to demonstrate cost-effectiveness and clinical implications. 25 There has been less research comprehensively exploring pharmacists' roles in supporting people living with severe and persistent mental illness; however, evidence in this area is emerging, with a recent systematic review highlighting pharmacists' roles in monitoring metabolic health among people living with severe mental illness and the need for further research to investigate the impact of these roles on clinical outcomes.…”

Section: 18mentioning

confidence: 99%

Pharmacists’ roles in mental healthcare: Past, present and future

El-Den¹,

Collins²,

Chen³

et al. 2021

Pharm Pract (Granada)

View full text Add to dashboard Cite

Mental illnesses cause significant disease burden globally, with medicines being a major modality of treatment for most mental illnesses. Pharmacists are accessible and trusted healthcare professionals who have an important role in supporting people living with mental illness. This commentary discusses the role of pharmacists in mental healthcare, as part of multidisciplinary teams, the current evidence to support these roles, and the training, remuneration and policy changes needed to recognize these roles and embed pharmacists as core members of the mental healthcare team.

show abstract

The role of community pharmacists in the identification and ongoing management of women at risk for perinatal depression: A qualitative study

Abstract: Pharmacists could potentially reinforce their involvement in mental health promotion activities.

Cited by 24 publications

References 69 publications

<p>The Potential Role of the Pharmacist in Supporting Patients with Depression – A Literature-Based Point of View</p>

<p>The Potential Role of the Pharmacist in Supporting Patients with Depression – A Literature-Based Point of View</p>

Perinatal depression screening: a systematic review of recommendations from member countries of the Organisation for Economic Co-operation and Development (OECD)

Pharmacists’ roles in mental healthcare: Past, present and future

Contact Info

Product

Resources

About